Positioning no disclosures inside 60 days, left as found
Options put/call open interest 12.69, read 2026-10-28
Ethical does not pass the values gate
Price10.66 USD
Fair value12.76
Ethical score30.0/100
Our investment reviews on this name
2026-10-28Read Distribution10.66+0.0% to today Markdown gives way to Distribution
2026-10-21Read Markdown10.70-0.4% to today ✓Distribution gives way to Markdown with volume flow in agreement
2026-10-02Read Distribution11.17-4.6% to today ✓Markup gives way to Distribution
2026-07-02Read Markup11.06-3.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
FS KKR Capital Corp. holds its Distribution at $10.66. The statistical read favours the sellers, held for 33 days.
As held on the ledger · 2026-10-27
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 33 days
Price at the screen
$10.66
Valuation
N/A trailing · 7.10 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.93
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: financial services
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: financial services
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
FS KKR Capital does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when FSK's ethical verdict changes
Today FSK does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-27 screen. The gold marker is the market price at the same screen. A 19.7% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Hold. The average target sits +13% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-27 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Middle Market Lender Trips Our Ethical Line
Picture a pension fund manager hunting yield by funding loans to mid-sized US firms that banks have turned away. FS KKR Capital Corp sits in exactly that spot, packaging senior debt for those borrowers. Yet the position fails our ethical screen outright because the whole sector carries a prohibited keyword.
The numbers reinforce why we pass. Revenue is down 24 percent, the profit margin sits at minus 39 percent and return on equity is negative 9 percent. A forward multiple of 7.1 times looks cheap until you remember those earnings are shrinking, not recovering.
Risk sits in the combination of thin margins and the ethical block that rules the name out regardless of any 14 percent gap to our fair value. Ten analysts call it a hold with an 11 dollar median target. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FSK trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Distribution$10.66+0.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-10-21Markdown · changed$10.70+0.0%Entry 8
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-10-14Distribution$10.70-4.2%Entry 7
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-08-30Markup$11.91+9.0%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-07-30Markup$10.93-1.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-07-18Markup$11.06+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 39%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (10 analysts) rates it hold, with a mean price target of $12.
2026-07-03Markup$11.06+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$11.06Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.